tm
Seeing Is Believing
tm
Seeing Is Believing
Viridian Therapeutics's activity chart (see below) currently has 17 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 23.75% with an average time for these price targets to be met of 72.5 days.
Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 31-Dec-2020. First documented stock forecast 21-Feb-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Mar-2019
$37
$19 (105.56%)
$180
5 years 10 months 1 days ago
(31-Dec-2020)
0/2 (0%)
$20.55 (124.92%)
Buy Since 21-Feb-2017
$15
$-3 (-16.67%)
$85.71
6 years 26 days ago
(06-Oct-2020)
1/5 (20%)
$6.28 (72.02%)
22
Buy Since 12-Jan-2018
$85.71
$67.71 (376.17%)
$195
6 years 3 months 11 days ago
(21-Jul-2020)
0/2 (0%)
$69.06 (414.77%)
Buy Since 25-Jul-2017
$15
$-3 (-16.67%)
$150
6 years 10 months 20 days ago
(12-Dec-2019)
1/5 (20%)
$5.47 (57.40%)
46
Buy Since 09-Mar-2018
$285
$267 (1483.33%)
8 years 7 months 24 days ago
(09-Mar-2018)
0/1 (0%)
$182.1 (176.97%)
What is MGEN (Viridian Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MGEN (Viridian Therapeutics)?
Which analyst has the current lower performing score on MGEN (Viridian Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MGEN (Viridian Therapeutics)?
Which analyst is the currently most bullish on MGEN (Viridian Therapeutics)?
Which analyst is the currently most reserved on MGEN (Viridian Therapeutics)?
